Skip to main content
. 2019 Apr 30;17:139. doi: 10.1186/s12967-019-1890-7

Table 1.

Demographic data and clinical characteristics of the study population

Group AMIAKI
(n = 30)
AMI+AKI
(n = 26)
AMI+AKI+
(n = 23)
AMIAKI+
(n = 29)
P-value
(four groups)
P-value
(AMI+AKI vs AMI+AKI+)
Age (years) 61 ± 3 59 ± 2 73 ± 2 71 ± 2 < 0.001 < 0.001
Sex, male (%) 19 (63.3) 22 (84.6) 19 (82.6) 19 (65.5) 0.165 0.576
Body weight (kg) 64.5 ± 1.9 68.9 ± 2.6 65.3 ± 2.3 64.9 ± 2.6 0.563 0.321
Diabetes mellitus (%) 7 (23.3) 7 (26.9) 12 (52.2) 16 (55.2) 0.023 0.064
Hypertension (%) 14 (46.7) 14 (53.8) 20 (87.0) 23 (79.3) 0.004 0.013
Coronary artery disease (%) 8 (26.7) 26 (100.0) 23 (100.0) 8 (27.6) < 0.001 1.000
Heart failure (%) 13 (43.3) 2 (7.7) 15 (65.2) 22 (75.9) < 0.001 < 0.001
Blood urea nitrogen (mg/dL) 15 ± 1 14 ± 1 40 ± 6 53 ± 6 < 0.001 < 0.001
Serum creatinine (mg/dL) 0.8 ± 0.1 0.9 ± 0.1 3.4 ± 0.5 3.0 ± 0.3 < 0.001 < 0.001
Serum NGAL (ng/mL) 72.0 ± 9.0 64.3 ± 7.5 140.1 ± 24.4 264.8 ± 56.1 < 0.001 0.007
WBC (103/μL) 8.2 ± 0.4 10.4 ± 0.6 12.6 ± 1.2 11.7 ± 2.0 0.071 0.096
Hemoglobin (g/dL) 13.0 ± 0.4 14.8 ± 0.2 12.2 ± 0.5 11.0 ± 0.5 < 0.001 < 0.001
Sugar (mg/dL) 122 ± 9 171 ± 18 183 ± 20 175 ± 15 0.033 0.671
ALT (U/L) 33 ± 6 31 ± 5 47 ± 11 88 ± 54 0.565 0.222
Albumin (g/L) 3.9 ± 0.1 3.9 ± 0.1 3.4 ± 0.1 3.3 ± 0.1 < 0.001 < 0.001
Troponin I (ng/mL) 2.30 ± 1.13 3.43 ± 1.47 15.98 ± 5.62 0.83 ± 0.27 0.005 0.041
BNP (pg/mL) 386 ± 112 243 ± 132 1098 ± 303 1460 ± 288 0.001 0.038
Mean arterial pressure (mmHg) 87 ± 3 89 ± 3 90 ± 3 86 ± 4 0.759 0.804
Ejection fraction (%) 55 ± 3 58 ± 3 48 ± 4 50 ± 4 0.226 0.050
Renal replacement therapy 0 (0) 0 (0) 3 (13.0) 4 (13.8) 0.021 0.096
In-hospital mortality 1 (3.3) 0 (0) 3 (13.0) 2 (6.9) 0.237 0.096

Values are mean ± standard error

AMI acute myocardial infarction, AKI acute kidney injury, ALT alanine aminotransferase, BNP B-type natriuretic peptide, BUN blood urea nitrogen, NGAL neutrophil gelatinase-associated lipocalin, RRT renal replacement therapy, WBC white blood cell